Taken together, these data demonstrate that SHIP restricts the development and immunosuppressive properties of myeloid cells, protects against severe necrohemorrhagic inflammatory pulmonary disease in BALB/c mice with 4T1 tumors, and represses the development of mammary tumor metastases. Here, INPP5D is linked to breast cancer.